Cosmos Health Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
Analyst Coverage
1analyst covering
FY Revenue (est.)
$84.3Mnext fiscal year
FY EPS (est.)
$0.01next fiscal year
Monitoring Framework
Key Performance Indicators
Quarterly Revenue Quarterly17.9MTarget: Surpass $90 million in FY 2026
CosmoFarm S.A. Quarterly Revenue Quarterly15MTarget: Annualized run-rate of over $60 million
Stockholders' Equity Quarterly19.8MTarget: $92.3 million by 2029
Watch Items
- Nasdaq Minimum Bid Price ComplianceTrigger: Stock price below $1.00Action: Monitor the 180-day compliance extension period to meet the minimum bid price requirement.
- U.S. Market Entry via 18 Series Nutraceutical PlatformTrigger: Initial commercial traction of launched productsAction: Track direct-to-consumer sales and expansion into retail channels to achieve the targeted $22.7 million annualized U.S. revenue.
- Debt and Convertible Note ReductionsTrigger: Total liabilities levelAction: Verify progress toward the goal of fully repaying all convertible notes by the end of 2026.
Research as of 20 Jun 2026